The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Transdermal Skin Patch Market Research Report 2024
Synopsis
The global Transdermal Skin Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Transdermal Skin Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Skin Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Transdermal Skin Patch include Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, Henan Lingrui Pharmaceutical and Changzhou Siyao, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Transdermal Skin Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Skin Patch.
Report Scope
The Transdermal Skin Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Skin Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Skin Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
Segment by Type
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch
Segment by Application
Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transdermal Skin Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transdermal Skin Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Transdermal Skin Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Transdermal Skin Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Skin Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Transdermal Skin Patch include Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, Henan Lingrui Pharmaceutical and Changzhou Siyao, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Transdermal Skin Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Skin Patch.
Report Scope
The Transdermal Skin Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Skin Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Skin Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
Segment by Type
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch
Segment by Application
Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transdermal Skin Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transdermal Skin Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Transdermal Skin Patch Market Overview
1.1 Product Overview and Scope of Transdermal Skin Patch
1.2 Transdermal Skin Patch Segment by Type
1.2.1 Global Transdermal Skin Patch Market Value Comparison by Type (2024-2030)
1.2.2 Fentanyl Transdermal Skin Patch
1.2.3 Nicotine Transdermal Skin Patch
1.2.4 Clonidine Transdermal Skin Patch
1.2.5 Buprenorphine Transdermal Skin Patch
1.3 Transdermal Skin Patch Segment by Application
1.3.1 Global Transdermal Skin Patch Market Value by Application: (2024-2030)
1.3.2 Relieve Severe Pain
1.3.3 Stop Smoking Cigarettes
1.3.4 Treat an Overactive Bladder
1.3.5 Others
1.4 Global Transdermal Skin Patch Market Size Estimates and Forecasts
1.4.1 Global Transdermal Skin Patch Revenue 2019-2030
1.4.2 Global Transdermal Skin Patch Sales 2019-2030
1.4.3 Global Transdermal Skin Patch Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Transdermal Skin Patch Market Competition by Manufacturers
2.1 Global Transdermal Skin Patch Sales Market Share by Manufacturers (2019-2024)
2.2 Global Transdermal Skin Patch Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Transdermal Skin Patch Average Price by Manufacturers (2019-2024)
2.4 Global Transdermal Skin Patch Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transdermal Skin Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Skin Patch, Product Type & Application
2.7 Transdermal Skin Patch Market Competitive Situation and Trends
2.7.1 Transdermal Skin Patch Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transdermal Skin Patch Players Market Share by Revenue
2.7.3 Global Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transdermal Skin Patch Retrospective Market Scenario by Region
3.1 Global Transdermal Skin Patch Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Transdermal Skin Patch Global Transdermal Skin Patch Sales by Region: 2019-2030
3.2.1 Global Transdermal Skin Patch Sales by Region: 2019-2024
3.2.2 Global Transdermal Skin Patch Sales by Region: 2025-2030
3.3 Global Transdermal Skin Patch Global Transdermal Skin Patch Revenue by Region: 2019-2030
3.3.1 Global Transdermal Skin Patch Revenue by Region: 2019-2024
3.3.2 Global Transdermal Skin Patch Revenue by Region: 2025-2030
3.4 North America Transdermal Skin Patch Market Facts & Figures by Country
3.4.1 North America Transdermal Skin Patch Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Transdermal Skin Patch Sales by Country (2019-2030)
3.4.3 North America Transdermal Skin Patch Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transdermal Skin Patch Market Facts & Figures by Country
3.5.1 Europe Transdermal Skin Patch Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Transdermal Skin Patch Sales by Country (2019-2030)
3.5.3 Europe Transdermal Skin Patch Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Country
3.6.1 Asia Pacific Transdermal Skin Patch Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Transdermal Skin Patch Sales by Country (2019-2030)
3.6.3 Asia Pacific Transdermal Skin Patch Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Transdermal Skin Patch Market Facts & Figures by Country
3.7.1 Latin America Transdermal Skin Patch Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Transdermal Skin Patch Sales by Country (2019-2030)
3.7.3 Latin America Transdermal Skin Patch Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Skin Patch Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Transdermal Skin Patch Sales by Country (2019-2030)
3.8.3 Middle East and Africa Transdermal Skin Patch Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Transdermal Skin Patch Sales by Type (2019-2030)
4.1.1 Global Transdermal Skin Patch Sales by Type (2019-2024)
4.1.2 Global Transdermal Skin Patch Sales by Type (2025-2030)
4.1.3 Global Transdermal Skin Patch Sales Market Share by Type (2019-2030)
4.2 Global Transdermal Skin Patch Revenue by Type (2019-2030)
4.2.1 Global Transdermal Skin Patch Revenue by Type (2019-2024)
4.2.2 Global Transdermal Skin Patch Revenue by Type (2025-2030)
4.2.3 Global Transdermal Skin Patch Revenue Market Share by Type (2019-2030)
4.3 Global Transdermal Skin Patch Price by Type (2019-2030)
5 Segment by Application
5.1 Global Transdermal Skin Patch Sales by Application (2019-2030)
5.1.1 Global Transdermal Skin Patch Sales by Application (2019-2024)
5.1.2 Global Transdermal Skin Patch Sales by Application (2025-2030)
5.1.3 Global Transdermal Skin Patch Sales Market Share by Application (2019-2030)
5.2 Global Transdermal Skin Patch Revenue by Application (2019-2030)
5.2.1 Global Transdermal Skin Patch Revenue by Application (2019-2024)
5.2.2 Global Transdermal Skin Patch Revenue by Application (2025-2030)
5.2.3 Global Transdermal Skin Patch Revenue Market Share by Application (2019-2030)
5.3 Global Transdermal Skin Patch Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Corporation Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Transdermal Skin Patch Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Transdermal Skin Patch Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Transdermal Skin Patch Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Transdermal Skin Patch Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Teikoku Pharma
6.4.1 Teikoku Pharma Corporation Information
6.4.2 Teikoku Pharma Description and Business Overview
6.4.3 Teikoku Pharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teikoku Pharma Transdermal Skin Patch Product Portfolio
6.4.5 Teikoku Pharma Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Transdermal Skin Patch Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Transdermal Skin Patch Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Actavis
6.6.1 Actavis Corporation Information
6.6.2 Actavis Description and Business Overview
6.6.3 Actavis Transdermal Skin Patch Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Actavis Transdermal Skin Patch Product Portfolio
6.6.5 Actavis Recent Developments/Updates
6.7 Mundipharma
6.6.1 Mundipharma Corporation Information
6.6.2 Mundipharma Description and Business Overview
6.6.3 Mundipharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mundipharma Transdermal Skin Patch Product Portfolio
6.7.5 Mundipharma Recent Developments/Updates
6.8 Henan Lingrui Pharmaceutical
6.8.1 Henan Lingrui Pharmaceutical Corporation Information
6.8.2 Henan Lingrui Pharmaceutical Description and Business Overview
6.8.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio
6.8.5 Henan Lingrui Pharmaceutical Recent Developments/Updates
6.9 Changzhou Siyao
6.9.1 Changzhou Siyao Corporation Information
6.9.2 Changzhou Siyao Description and Business Overview
6.9.3 Changzhou Siyao Transdermal Skin Patch Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Changzhou Siyao Transdermal Skin Patch Product Portfolio
6.9.5 Changzhou Siyao Recent Developments/Updates
6.10 Rfl Pharmaceutical
6.10.1 Rfl Pharmaceutical Corporation Information
6.10.2 Rfl Pharmaceutical Description and Business Overview
6.10.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio
6.10.5 Rfl Pharmaceutical Recent Developments/Updates
6.11 Luye Pharma Group Ltd.
6.11.1 Luye Pharma Group Ltd. Corporation Information
6.11.2 Luye Pharma Group Ltd. Transdermal Skin Patch Description and Business Overview
6.11.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolio
6.11.5 Luye Pharma Group Ltd. Recent Developments/Updates
6.12 Purdue Pharma L.P.
6.12.1 Purdue Pharma L.P. Corporation Information
6.12.2 Purdue Pharma L.P. Transdermal Skin Patch Description and Business Overview
6.12.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Purdue Pharma L.P. Transdermal Skin Patch Product Portfolio
6.12.5 Purdue Pharma L.P. Recent Developments/Updates
6.13 Teva Pharmaceutical Industries Ltd.
6.13.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.13.2 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Description and Business Overview
6.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolio
6.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Skin Patch Industry Chain Analysis
7.2 Transdermal Skin Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Skin Patch Production Mode & Process
7.4 Transdermal Skin Patch Sales and Marketing
7.4.1 Transdermal Skin Patch Sales Channels
7.4.2 Transdermal Skin Patch Distributors
7.5 Transdermal Skin Patch Customers
8 Transdermal Skin Patch Market Dynamics
8.1 Transdermal Skin Patch Industry Trends
8.2 Transdermal Skin Patch Market Drivers
8.3 Transdermal Skin Patch Market Challenges
8.4 Transdermal Skin Patch Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
